MMP14 and glioma: To assess whether TMZ and XRT will benefit from MMP14 silencing, we divided U251 glioma-bearing mice into four different treatment groups: shScramble, shMMP14, shScramble+TMZ+XRT, and shMMP14+TMZ+XRT.